News for ARYx Therapeutics, Inc. - Google FinanceNews for ARYx Therapeutics, Inc. - Google FinanceARYx Therapeutics Appoints Amgen Executive to Board of Directors- August 29, 2008 ARYx Therapeutics Appoints Amgen Executive to Board of Directors MarketWatch - Aug 29, 2008 , , ) today announced the appointment of David Beier to its board of directors.Mr . Beier is a veteran of the biotechnology industry and has been instrumental in the development of United States ...http://www.marketwatch.com/news/story/aryx-therapeutics-appoints-amgen-executive/story.asp... ARYx Gets Good News From Chronic Constipation Clinical Trial- August 26, 2008 ARYx Gets Good News From Chronic Constipation Clinical Trial FDA news (subscription) - Aug 26, 2008 Despite its early termination , a Phase IIb study yielded positive outcomes in studying ARYx Therapeutics ' prokinetic agent ATI - 7505 in patients with chronic idiopathic constipation.Conducted ...http://fdanews.com/newsletter/article?issueId=11899&articleId=109821 ARYx Therapeutics, Inc. Announces Successful Results Of Chronic Constipation Clinical Trial On ATI-7505- August 26, 2008 ARYx Therapeutics, Inc. Announces Successful Results Of Chronic Constipation Clinical Trial On ATI-7505 Medical News Today (press release) - Aug 26, 2008 ARYx Therapeutics , Inc . , ( NASDAQ : ARYX ) , a biopharmaceutical company , announced the results of a Phase 2b clinical trial testing the safety and efficacy of its prokinetic agent , ATI ...http://www.medicalnewstoday.com/articles/119214.php ARYx reports positive results from Phase IIb constipation trial- August 25, 2008 ARYx reports positive results from Phase IIb constipation trial Trading Markets (press release) - Aug 25, 2008 Aug 25 , 2008 ( Datamonitor via COMTEX ) - - ARYX Quote Chart News PowerRating - - ARYx Therapeutics has announced the positive results of a Phase IIb clinical trial testing the safety ...http://www.tradingmarkets.com/.site/news/Stock%20News/1843559/ ARYx Therapeutics, Inc. Announces Successful Results of Chronic Constipation Clinical Trial on ATI-7505- August 22, 2008 ARYx Therapeutics, Inc. Announces Successful Results of Chronic Constipation Clinical Trial on ATI-7505 MarketWatch - Aug 22, 2008 , , ) , a biopharmaceutical company , today announced the results of a Phase 2b clinical trial testing the safety and efficacy of its prokinetic agent , ATI - 7505 , in patients with chronic ... ARYx Therapeutics announces results of Phase 2b clinical trial of prokinetic agent ATI-7505 - Update - RTT Newshttp://www.marketwatch.com/news/story/aryx-therapeutics-inc-announces-successful/story.asp... ARYx Reports Second Quarter 2008 Financial Results- August 13, 2008 ARYx Reports Second Quarter 2008 Financial Results MarketWatch - Aug 13, 2008 notes required by US generally accepted accounting principles for complete financial statement presentation.Condensed Consolidated Statements of Operations ( in thousands , except per share amount ... ARYx Therapeutics Q2 net loss widens - Update - RTT Newshttp://www.marketwatch.com/news/story/aryx-reports-second-quarter-2008/story.aspx?guid=%7B... ARYx Therapeutics Schedules Second Quarter 2008 Results and Earnings Call- August 6, 2008 ARYx Therapeutics Schedules Second Quarter 2008 Results and Earnings Call Business Wire (press release) - Aug 6, 2008 FREMONT , Calif . - - ( BUSINESS WIRE ) - - ARYx Therapeutics Inc . ( NASDAQ : ARYX ) , a biopharmaceutical company , announced today that a conference call to discuss second quarter 2008 results ...http://www.businesswire.com/news/google/20080806006252/en |